Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
153.1 USD | -0.71% |
|
-2.42% | +58.78% |
06-26 | Monetary policy is getting even more confusing | ![]() |
06-26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.78% | 14.47B | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+4.91% | 13.91B | |
+100.06% | 10B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Transcript : Sarepta Therapeutics, Inc. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 10